Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
Clinical trial NCT01838044 · TERMINATED
Trial details
- NCT number
- NCT01838044
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.